• 1
    Pajvani UB, Du X., Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 90739085.
  • 2
    Delaigle AM, Jonas J-C, Bauche IB, Cornu O., Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004; 145: 55895597.
  • 3
    Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 25482556.
  • 4
    Sell H., Dietze-Schroeder D., Eckardt K., Eckel J.. Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone. Biochem Biophys Res Commun 2006; 343: 700706.
  • 5
    Aldhahi W., Hamdy O.. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003; 3: 293298.
  • 6
    Scherer PE, Williams S., Fogliano M., Baldini G., Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 2674626749.
  • 7
    Hotta K., Funahashi T., Arita Y. et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 15951599.
  • 8
    Tsao T-S, Murrey HE, Hug C., Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002; 277: 2935929362.
  • 9
    Kim K-Y, Kim JK, Han SH et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 2006; 176: 59585964.
  • 10
    Ouchi N., Kihara S., Arita Y. et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 24732476.
  • 11
    Salmenniemi U., Ruotsalainen E., Pihlajamaki J. et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004; 110: 38423848.
  • 12
    Lara-Castro C., Luo N., Wallace P., Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249259.
  • 13
    Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1220R1225.
  • 14
    Tsao T-S, Tomas E., Murrey HE et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 5081050817.
  • 15
    Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939949.
  • 16
    Fruebis J., Tsao TS, Javorschi S.. et al Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 20052010.
  • 17
    Yamauchi T., Kamon J., Minokoshi Y. et al Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 12881295.
  • 18
    Onay-Besikci A., Altarejos JY, Lopaschuk GD. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. J Biol Chem 2004; 279: 4432044326.
  • 19
    Bluher M., Bullen JW, Jr, Lee JH et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006; 91: 23102316.
  • 20
    Chen H., Montagnani M., Funahashi T., Shimomura I., Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 4502145026.
  • 21
    Hattori Y., Suzuki M., Hattori S., Kasai K.. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003; 46: 15431549.
  • 22
    Xi W., Satoh H., Kase H., Suzuki K., Hattori Y.. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun 2005; 332: 200205.
  • 23
    Ouchi N., Kihara S., Arita Y. et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 12961301.
  • 24
    Matsuzawa Y.. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005; 19: 637647.
  • 25
    Arita Y., Kihara S., Ouchi N. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 7983.
  • 26
    Hu E., Liang P., Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 1069710703.
  • 27
    Kumada M., Kihara S., Sumitsuji S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 8589.
  • 28
    Vilarrasa N., Vendrell J., Maravall J. et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin Endocrinol 2005; 63: 329335.
  • 29
    Balagopal P., George D., Yarandi H., Funanage V., Bayne E.. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005; 90: 61926197.
  • 30
    Esposito K., Pontillo A., Di Palo C. et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 17991804.
  • 31
    Faraj M., Havel PJ, Phelis S. et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 15941602.
  • 32
    Oberbach A., Tonjes A., Kloting N. et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006; 154: 577585.
  • 33
    Manigrasso MR, Ferroni P., Santilli F. et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005; 90: 58765879.
  • 34
    Hulver MW, Zheng D., Tanner CJ et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 2002; 283: E861E865.
  • 35
    Fatouros IG, Tournis S., Leontsini D. et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 2005; 90: 59705977.
  • 36
    Giannopoulou I., Fernhall B., Carhart R. et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005; 54: 866875.
  • 37
    Bruun JM, Helge JW, Richelsen B., Stallknecht B.. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006; 290: E961E967.
  • 38
    Herbert RD. Confidence Interval Calculator Version 4.1. (Updated 26/01/04) <> (2004). Accessed 24 August 2006.
  • 39
    Becker LA. Effect Size Calculators. (Revised 20/03/00) <http:web.uccs.edulbeckerPsy590escalc3.htm> (1999). Accessed 25 September 2006.
  • 40
    Middel B., van Sonderen E.. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care 2002; 2: 122.
  • 41
    Diabetes Trials Unit. HOMA Calculator Version 2.2. (Updated 30/06/04) <> (2004). Accessed 19 November 2006.
  • 42
    Verhagen AP, de Vet HC, de Bie RA et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 12351241.
  • 43
    Troseid M., Lappegard KT, Mollnes TE, Arnesen H., Seljeflot I.. Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand J Clin Lab Invest 2005; 65: 283290.
  • 44
    Ryan AS, Nicklas BJ, Berman DM, Elahi D.. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 2003; 27: 10661071.
  • 45
    Ferguson MA, White LJ, McCoy S. et al. Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 2004; 91: 324329.
  • 46
    Hara T., Fujiwara H., Nakao H. et al. Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. Eur J Appl Physiol 2005; 94: 520526.
  • 47
    Conus F., Allison DB, Rabasa-Lhoret R. et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89: 50135020.
  • 48
    Yokoyama H., Hirose H., Ohgo H., Saito I.. Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 2004; 43: 453457.
  • 49
    Tsukinoki R., Morimoto K., Nakayama K.. Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 2005; 4: 27.
  • 50
    St-Pierre DH, Faraj M., Karelis AD et al. Lifestyle behaviours and components of energy balance as independent predictors of ghrelin and adiponectin in young non-obese women. Diabetes Metab 2006; 32: 131139.
  • 51
    Kondo T., Kobayashi I., Murakami M.. Effect of exercise on circulating adipokine levels in obese young women. Endocr J 2006; 53: 189195.
  • 52
    Nassis GP, Papantakou K., Skenderi K. et al. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism 2005; 54: 14721479.
  • 53
    Polak J., Klimcakova E., Moro C. et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women. Metabolism 2006; 55: 13751381.
  • 54
    Boudou P., Sobngwi E., Mauvais-Jarvis F., Vexiau P., Gautier JF. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003; 149: 421424.
  • 55
    Jamurtas AZ, Theocharis V., Koukoulis G. et al. The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J Appl Physiol 2006; 97: 122126.
  • 56
    Jurimae J., Purge P., Jurimae T.. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 2005; 93: 502505.
  • 57
    Jurimae J., Purge P., Jurimae T.. Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers. Metabolism 2006; 55: 1319.
  • 58
    Jurimae J., Purge P., Jurimae T., von Duvillard SP. Bone metabolism in elite male rowers: adaptation to volume-extended training. Eur J Appl Physiol 2006; 97: 127132.
  • 59
    Kraemer RR, Aboudehen KS, Carruth AK et al. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc 2003; 35: 13201325.
  • 60
    Punyadeera C., Zorenc AHG, Koopman R. et al. The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 2005; 152: 427436.
  • 61
    Yatagai T., Nishida Y., Nagasaka S. et al. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003; 50: 233238.
  • 62
    Brekke HK, Lenner RA, Taskinen M-R et al. Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Res Clin Pract 2005; 68: 1828.
  • 63
    Hsieh CJ, Wang PW. Effectiveness of weight loss in the elderly with type 2 diabetes mellitus. J Endocrinol Invest 2005; 28: 973977.
  • 64
    Marcell TJ, McAuley KA, Traustadottir T., Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism 2005; 54: 533541.
  • 65
    O'Leary VB, Marchetti CM, Krishnan RK et al. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol 2006; 100: 15841589.
  • 66
    Yokoyama H., Emoto M., Araki T. et al. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes. Diabetes Care 2004; 27: 17561758.
  • 67
    Taylor HL, Jacobs DR, Jr, Schucker B. et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978; 31: 741755.
  • 68
    Belloc NB, Breslow L.. Relationship of physical health status and health practices. Prev Med 1972; 1: 409421.